Skip to main navigation Skip to search Skip to main content

Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma

  • Sungkyunkwan University

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology